For example, the activation of the MAPK and p53 signaling pathways was found as a result of CAP exposure in the non-small-cell lung cancer A549 cell, resulting in changes of expression for MEKK, GADD, FOS, and JUN35. Here, MAP3K1 is linked to non-small cell lung carcinoma.